Cargando…
Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with l-phenylglycine scaffold
In our previous research, a novel series of histone deacetylase (HDAC) inhibitors with l-phenylglycine scaffold were designed and synthesized, among which amides D3 and D7 and ureido D18 were far superior to the positive control (suberoylanilide hydroxamic acid [SAHA]) in HDAC inhibition, but were o...
Autores principales: | Zhang, Yingjie, Li, Xiaoguang, Hou, Jinning, Huang, Yongxue, Xu, Wenfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603714/ https://www.ncbi.nlm.nih.gov/pubmed/26504374 http://dx.doi.org/10.2147/DDDT.S94037 |
Ejemplares similares
-
Discovery of the First N-Hydroxycinnamamide-Based
Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor
Activity
por: Li, Xiaoyang, et al.
Publicado: (2014) -
Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018) -
Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
por: Gao, Yuan, et al.
Publicado: (2023) -
Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold
por: Wang, Bin, et al.
Publicado: (2023) -
Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities
por: Yang, Feifei, et al.
Publicado: (2019)